Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Objective: Medication nonadherence has not been well characterized in systemic lupus erythematosus (SLE). Our objective was to a conduct a systematic review of the literature, examining the burden and determinants of medication nonadherence in SLE. Methods: We conducted a systematic search of Medline (1946–2015), Embase (1974–2015), and Web of Science (1900–2015) databases and selected original studies of SLE patients that evaluated nonadherence to SLE therapies as the primary study outcome. We extracted information on study design, sample size, length of followup, data sources, type of nonadherence problem examined, adherence measures and reported estimates, and determinants of adherence reported in multivariable analyses. Results: After screening 4,111 titles, 11 studies met the inclusion criteria. Study sample sizes ranged from 32 to 246 patients, and studies were categorized according to data source: self‐report (5), electronic monitoring devices (1), clinical records from rheumatology clinics (3), and refill information from pharmacy records (2). Overall, the percentage of nonadherent patients ranged from 43% to 75%, with studies consistently reporting that over half of patients are nonadherent. Studies also showed that up to 33% of patients discontinue therapy after 5 years. Determinants of nonadherence included having depression, rural residence, lower education level, and polypharmacy. Conclusion: Overall, synthesis of current evidence suggests that the burden of medication nonadherence is substantial in SLE. Findings highlight the importance of developing interventions to support adherence and improve outcomes among patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272 · cited 1×
“Using the World Health Organization’s “Five Dimensions of Adherence” as a framework, we also extracted information on determinants or factors shown to be independently associated with adherence in multivariable analyses, grouping them according to: 1) patient factors, 2) condition factors, 3) therapy factors, 4) socia…”
MethodConcurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317 · cited 2×
“The key determinants of nonadherence that were reported in multiple studies were having lower education (16,17), depression (17,18), and polypharmacy (17,18).”
BackgroundMethodMedication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488 · cited 1×
“We excluded randomized controlled trials (RCTs) as we were primarily interested in treatment of patients in clinical or real-world settings because medication adherence has been shown to be higher among patients participating in clinical drug trials (9).”
MethodThe assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193 · cited 1×
“These pharmacies were contacted, and the 4 most recent medication prescriptions (amounts and dates) were collected, the MPR was calculated, and patients were categorized as adherent (MPR ≥80%) or nonadherent (MPR <80%) (25).”
MethodMortality in systemic lupus erythematosus
Bernatsky, S., Boivin, J. ‐., Joseph, L., Manzi, S., Ginzler, E., Gladman, D. D., Urowitz, M., Fortin, P. R., Petri, M., Barr, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21955 · Cited by 1,181 · cited 1×
“Advances in SLE treatments over the last few decades have resulted in marked decreases in deaths associated with SLE activity (7), but there seems to be no such decline in deaths associated with the sequelae of SLE (7).”
BackgroundBertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007 · cited 3×
“Second, some of these studies did not specify the medications being studied, which is problematic, because some medications such as prednisone are used primarily on a temporary basis to treat flares and are not intended for long-term use, unlike antimalarials or immunosuppressive agents (5,6).”
BackgroundHess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 756 · cited 1×
“None of the included studies used administrative electronic prescription records to assess adherence, which counters the recent trends of the increased use and wide acceptance of retrospective, computerized databases for medication adherence research (27,28).”
BackgroundA Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases
Peterson, A. M., Nau, D. P., Cramer, J. A., Benner, J., Gwadry-Sridhar, F., & Nichol, M. (2007) · Value in Health · doi:10.1111/j.1524-4733.2006.00139.x · Cited by 633 · cited 1×
“13 prescription records to assess adherence, which counters the recent trends of the increased use and wide acceptance of retrospective, computerized databases for medication adherence research (27, 28).”
BackgroundFeldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., Winkelmayer, W. C., & Costenbader, K. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37795 · Cited by 487
Manifestations of systemic lupus erythematosus.
Cojocaru, M., Cojocaru, I. M., Siloşi, I., & Vrabie, C. D. (2011) · PubMed Central · Cited by 400
Primer on the Rheumatic Diseases
(2008) · Springer eBooks · doi:10.1007/978-0-387-68566-3 · Cited by 253
Depression, medication adherence, and service utilization in systemic lupus erythematosus
Julian, L. J., Yelin, E., Yazdany, J., Panopalis, P., Trupin, L., Criswell, L. A., & Katz, P. (2009) · Arthritis Care & Research · doi:10.1002/art.24236 · Cited by 192 · cited 2×
“Julian et al (31) showed that patients who had problems with forgetting to take medications had significantly greater numbers of outpatient rheumatology and primary care visits and were more likely to visit the emergency department (odds ratio 1.”
BackgroundInfluentialAdherence to treatment in systemic lupus erythematosus patients
Costedoat-Chalumeau, N., Pouchot, J., Guettrot-Imbert, G., Le Guern, V., Leroux, G., Marra, D., Morel, N., & Piette, J.-C. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2013.07.001 · Cited by 190 · cited 1×
“This work also builds on a recent review article by Costedoat-Chalumeau et al (32) through systematic searching of the literature and comprehensive capture of studies.”
BackgroundFeldman, C. H., Yazdany, J., Guan, H., Solomon, D. H., & Costenbader, K. H. (2015) · Arthritis Care & Research · doi:10.1002/acr.22636 · Cited by 144 · cited 3×
“Using US Medicaid data, Feldman et al (29) showed higher risks of emergency department visits and hospitalizations among nonadherent as compared to adherent users of hydroxychloroquine and immunosuppressive medications, respectively.”
BackgroundInfluentialHarrold, L. R., & Andrade, S. E. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.01.011 · Cited by 141 · cited 1×
“To date, 1 systematic review in 2009 has summarized medication nonadherence across a variety of rheumatic diseases, including 4 studies published from 1999 to 2006 that reported adherence rates among SLE patients (8).”
BackgroundTreatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus
García-González, A., Richardson, M. N., Popa‐lisseanu, M. G. G., Cox, V., Kallen, M. A., Janssen, N. M., Ng, B., Marcus, D. M., Reveille, J. D., & Suarez-Almazor, M. E. (2008) · Clinical Rheumatology · doi:10.1007/s10067-007-0816-6 · Cited by 134 · cited 4×
“complete nonadherence and 100 = perfect adherence) (13).”
BackgroundInfluentialMosley‐Williams, A., Lumley, M. A., Gillis, M., Leisen, J., & Guice, D. (2002) · Arthritis Care & Research · doi:10.1002/art.10790 · Cited by 126 · cited 3×
“Mosley-Williams et al (12) queried 122 patients (68 African American women and 54 white women) from 2 rheumatology clinics at urban tertiary care medical centers regarding the frequency of failing to take their SLE medications on a 5-point scale (where 1 = never, 2 = rarely, 3 = sometimes, 4 = often, and 5 = all the t…”
BackgroundInfluentialAdherence To Medications In Systemic Lupus Erythematosus
Koneru, S., Kocharla, L. P., Higgins, G. C., Ware, A. E., Passo, M. H., Farhey, Y., Mongey, A., Graham, T. B., Houk, J. L., & Brunner, H. I. (2008) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31817a242a · Cited by 124 · cited 6×
“conducted 2 studies (22,23) examining medication adherence in SLE using pharmacy refill information.”
BackgroundInfluentialCastrejón, I., Tani, C., Jolly, M., Huang, A., & Mosca, M. (2014) · PubMed · Cited by 114
Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus
Daleboudt, G. M. N., Broadbent, E., McQueen, F., & Kaptein, A. A. (2011) · Arthritis Care & Research · doi:10.1002/acr.20411 · Cited by 102 · cited 3×
“Daleboudt et al (14) New Zealand Secondary 106 NA Yes 16”
BackgroundInfluentialKoneru, S., Shishov, M., Ware, A., Farhey, Y., Mongey, A., Graham, T. B., Passo, M. H., Houk, J. L., Higgins, G. C., & Brunner, H. I. (2007) · Arthritis Care & Research · doi:10.1002/art.22898 · Cited by 102
Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang, C., Fortin, P. R., Li, Y., Panaritis, T., Gans, M., & Esdaile, J. M. (1999) · PubMed · Cited by 96
Self-citationTextbook of Pharmacoepidemiology
Strom, B. L., & Kimmel, S. E. (2006) · Wiley eBooks · doi:10.1002/9781118707999 · Cited by 86
Measuring therapeutic adherence in systemic lupus erythematosus with electronic monitoring
Marengo, M. F., Waimann, C., de Achaval, S., Zhang, H., García-González, A., Richardson, M., Reveille, J. D., & Suarez-Almazor, M. E. (2012) · Lupus · doi:10.1177/0961203312447868 · Cited by 85 · cited 7×
“Among condition factors, having depression was associated with non-adherence in 2 studies (17, 18).”
BackgroundMethodInfluentialRojas‐Serrano, J., & Cardiel, M. H. (2000) · Lupus · doi:10.1191/096120300678828785 · Cited by 81
Morand, E. F., McCloud, P., & Littlejohn, G. O. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.12.1318 · Cited by 67 · cited 4×
“stopping including remission (7 patients) and inefficiency (4 patients) (19).”
BackgroundMethodInfluentialEvaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil
Oliveira-Santos, M., Verani, J. F. D. S., Klumb, E. M., & Albuquerque, E. (2010) · Lupus · doi:10.1177/0961203310383736 · Cited by 54
Abdul-Sattar, A. B., & El-Magd, S. A. A. (2014) · Rheumatology International · doi:10.1007/s00296-014-3182-0 · Cited by 51 · cited 10×
“5% of patients were nonadherent to their SLE medication regimen (17).”
BackgroundMethodInfluential
Cited by
Wang, J., Nakamura, T. I., Tuskey, A. G., & Behm, B. W. (2019) · Intestinal Research · doi:10.5217/ir.2019.00050 · Cited by 31
Metadata
- Authors
- Mehat, P., Atiquzzaman, M., Esdaile, J. M., AviÑa‐Zubieta, A., & De Vera, M. A.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2017-09-21
- Volume
- 69
- Issue
- 11
- Pages
- 1706-1713
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W2575131381
- Cited by
- 160
- References
- 30
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.